Actinium Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Actinium Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 362.96% higher than the current stock price, while the lowest is $2.00 (+85.19%) and the highest is $9.00 (+733.33%).

Price Target: $5.00 (+362.96%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$5.00	$5.00	$9.00
Change	+85.19%	+362.96%	+362.96%	+733.33%

Analyst Ratings

The average analyst rating for Actinium Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $4	Buy	Reiterates	$4	+270.37%	May 12, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Maintains $5	Buy	Maintains	$5	+362.96%	Apr 8, 2026
Justin Walsh JonesTrading	JonesTrading	Buy Reiterates $9	Buy	Reiterates	$9	+733.33%	Apr 3, 2026

Financial Forecast

Revenue This Year

n/a

from 90.00K

-100.00%

from 90.00K

Revenue Next Year

9.70M

EPS This Year

-0.84

from -1.09

EPS Next Year

-0.48

from -0.84

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.14M	1.03M	81.00K	-	90.00K	-
Revenue Growth	-	-9.97%	-92.14%	-	-	-100.00%
Gross Profit	1.14M	1.03M	81.00K	-	90.00K	-
Gross Margin	100.00%	100.00%	100.00%	-	100.00%	-
Operating Income	-24.96M	-34.10M	-51.92M	-42.12M	-36.25M	-29.23M
Net Income	-24.77M	-33.02M	-48.82M	-38.24M	-33.89M	-28.04M
EPS	-	-	-	-	-1.09	-0.84
Free Cash Flow	-11.88M	-14.70M	-29.70M	-20.63M	-12.85M	-15.63M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.84
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-